HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Number of Blades-up Runs Using JetStream XC Atherectomy for Optimal Tissue Debulking in Patients with Femoropopliteal Artery In-Stent Restenosis.

Abstract
Rotational atherectomy with the use of the JetStream XC device is indicated for treatment of infrainguinal arterial obstructive disease. The number of blades-up (BU) runs needed for optimal tissue debulking in femoropopliteal in-stent restenosis (ISR) is unknown. In the present series, 6 patients (15 lesions) were treated for femoropopliteal ISR with the JetStream XC device. Minimal luminal diameter or percent stenosis improved significantly from baseline after 2 BU runs, but no further gain was seen between 2 and 4 BU runs (P > .05). However, adjunctive balloon angioplasty reduced percent stenosis significantly following BU runs. In conclusion, the JetStream XC device achieved optimal acute angiographic results in treating femoropopliteal ISR following 2 BU runs and adjunctive balloon angioplasty.
AuthorsNicolas W Shammas, Gail A Shammas, Nicole Aasen, Gary Jarvis
JournalJournal of vascular and interventional radiology : JVIR (J Vasc Interv Radiol) Vol. 26 Issue 12 Pg. 1847-51 (Dec 2015) ISSN: 1535-7732 [Electronic] United States
PMID26596178 (Publication Type: Clinical Trial, Journal Article)
CopyrightCopyright © 2015 SIR. Published by Elsevier Inc. All rights reserved.
Topics
  • Aged
  • Atherectomy (instrumentation, methods)
  • Equipment Design
  • Equipment Failure Analysis
  • Female
  • Femoral Artery (diagnostic imaging, surgery)
  • Graft Occlusion, Vascular (diagnostic imaging, surgery)
  • Humans
  • Male
  • Popliteal Artery (diagnostic imaging, surgery)
  • Radiography
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: